ClariTrial | Search Clinical Trials

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

233 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia

Phase 2X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

ER004

EspeRare Foundation20 participants8 sites · United States, France, GermanyCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Phase 2Atopic Dermatitis (AD)

ENV-294Placebo

Enveda Therapeutics60 participants23 sites · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Swiss Itch Registry

N/APruritus

Data collection

University Hospital, Basel, Switzerland100 participants1 site · SwitzerlandCompletes Oct 2033

Compare CT.gov Full analysis →

Recruiting

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Phase 3Eczema

AbrocitinibPlacebo

Pfizer150 participants41 sites · United States, China, GermanyCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

Microbiome in Atopic Dermatitis Under Systemic Therapy

N/AAtopic Dermatitis

not applicable, observational study

Charite University, Berlin, Germany600 participants1 site · GermanyCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

N/AAtopic Dermatitis

Sanofi600 participants62 sites · FranceCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Phase 4Respiratory Tract InfectionsInfectionsAllergy

Measles-Mumps-Rubella vaccine (MMR)

Laure Pittet, MD-PhD500 participants1 site · SwitzerlandCompletes Apr 2026

Compare CT.gov Full analysis →

Recruiting

Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

Phase 2Hypereosinophilic Syndrome

dupilumab

National Institute of Allergy and Infectious Diseases (NIAID)30 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

N/ACutaneous T Cell Lymphoma

Northwestern University300 participants1 site · United StatesCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis

Phase 2Moderate-to-severe Atopic Dermatitis

SHR-1905 InjectionSHR-1905 Injection Blank Preparation

Guangdong Hengrui Pharmaceutical Co., Ltd75 participants1 site · ChinaCompletes Sep 2026

Compare CT.gov Full analysis →

Recruiting

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

N/AAtopic Dermatitis

CorEvitas1,500 participants1 site · United StatesCompletes Dec 2099

Compare CT.gov Full analysis →

Recruiting

Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.

N/AAtopic Dermatitis (AD)Atopic Dermatitis (Eczema)

Hôpitaux Drôme Nord15 participants1 site · FranceCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

Phase 3AsthmaRespiratory Tract InfectionsGastrointestinal Infection

Cholecalciferol D3Olive oil

Professor Klaus Bønnelykke2,000 participants1 site · DenmarkCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Study of Alloknesia in Atopic Dermatitis

N/AAtopic DermatosisAlloknesie

University Hospital, Brest160 participants8 sites · FranceCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Prevalence of FGIDs and Probiotics Study

N/AFunctional Gastrointestinal DisordersInfant Conditions

BiogaiaPlacebo

Chulalongkorn University512 participants1 site · ThailandCompletes Feb 2026

Compare CT.gov Full analysis →

1–15 of 233

Explore/atopic dermatitis

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

233 results for “atopic dermatitis” · Recruiting

Page 1 of 16

Recruiting

Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia

Phase 2X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)

ER004

EspeRare Foundation20 participants8 sites · United States, France, GermanyCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Phase 2Atopic Dermatitis (AD)

ENV-294Placebo

Enveda Therapeutics60 participants23 sites · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Swiss Itch Registry

N/APruritus

Data collection

University Hospital, Basel, Switzerland100 participants1 site · SwitzerlandCompletes Oct 2033

Compare CT.gov Full analysis →

Recruiting

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Phase 3Eczema

AbrocitinibPlacebo

Pfizer150 participants41 sites · United States, China, GermanyCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

Microbiome in Atopic Dermatitis Under Systemic Therapy

N/AAtopic Dermatitis

not applicable, observational study

Charite University, Berlin, Germany600 participants1 site · GermanyCompletes Dec 2025

Compare CT.gov Full analysis →

Recruiting

French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

N/AAtopic Dermatitis

Sanofi600 participants62 sites · FranceCompletes May 2027

Compare CT.gov Full analysis →

Recruiting

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Phase 4Respiratory Tract InfectionsInfectionsAllergy

Measles-Mumps-Rubella vaccine (MMR)

Laure Pittet, MD-PhD500 participants1 site · SwitzerlandCompletes Apr 2026

Compare CT.gov Full analysis →

Recruiting

Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents

Phase 2Hypereosinophilic Syndrome

dupilumab

National Institute of Allergy and Infectious Diseases (NIAID)30 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

N/ACutaneous T Cell Lymphoma

Northwestern University300 participants1 site · United StatesCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis

Phase 2Moderate-to-severe Atopic Dermatitis

SHR-1905 InjectionSHR-1905 Injection Blank Preparation

Guangdong Hengrui Pharmaceutical Co., Ltd75 participants1 site · ChinaCompletes Sep 2026

Compare CT.gov Full analysis →

Recruiting

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

N/AAtopic Dermatitis

CorEvitas1,500 participants1 site · United StatesCompletes Dec 2099

Compare CT.gov Full analysis →

Recruiting

Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.

N/AAtopic Dermatitis (AD)Atopic Dermatitis (Eczema)

Hôpitaux Drôme Nord15 participants1 site · FranceCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

Phase 3AsthmaRespiratory Tract InfectionsGastrointestinal Infection

Cholecalciferol D3Olive oil

Professor Klaus Bønnelykke2,000 participants1 site · DenmarkCompletes Oct 2026

Compare CT.gov Full analysis →

Recruiting

Study of Alloknesia in Atopic Dermatitis

N/AAtopic DermatosisAlloknesie

University Hospital, Brest160 participants8 sites · FranceCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Prevalence of FGIDs and Probiotics Study

N/AFunctional Gastrointestinal DisordersInfant Conditions

BiogaiaPlacebo

Chulalongkorn University512 participants1 site · ThailandCompletes Feb 2026

Compare CT.gov Full analysis →

1–15 of 233